Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CPA1 | P15085 | 1/20 | 0.47 |
| ▸ | CPA2 | P48052 | 1/20 | 0.47 |
| ▸ | CPA4 | Q9UI42 | 1/20 | 0.47 |
| ▸ | ANPEP | P15144 | 1/20 | 0.47 |
| ▸ | TLR2 | O60603 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.46 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | GNPAT | O15228 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP3 | P08254 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24701921 | 1.00 | NPC1 (0.52) | NPC1RAB9AMMP2LMNACPA1 | |
| SCHEMBL20844609 | 1.00 | NPC1 (0.52) | NPC1RAB9AMMP2LMNACPA1 | |
| SCHEMBL12285408 | 0.89 | CPA1 (0.59) | NPC1RAB9AMMP2LMNACPA1 | |
| SCHEMBL21788139 | 0.88 | GNPAT (0.53) | MMP2GNPATMMP1MMP3 | |
| SCHEMBL20844610 | 0.87 | NPC1 (0.52) | NPC1RAB9ALMNATAAR1SLC18A2 | |
| SCHEMBL12947602 | 0.86 | MMP2 (0.61) | NPC1RAB9AMMP2MMP1MMP3 | |
| SCHEMBL20159738 | 0.86 | MMP2 (0.57) | MMP2GNPATMMP1MMP3 | |
| SCHEMBL3183858 | 0.85 | MMP2 (0.48) | NPC1RAB9AMMP2CPA1CPA2 | |
| SCHEMBL12288572 | 0.85 | GNPAT (0.58) | NPC1RAB9AMMP2LMNACPA1 | |
| SCHEMBL30917923 | 0.85 | GNPAT (0.61) | MMP2TLR2GNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4098248-A1 | ORAL SOLUTIONS COMPRISING LISDEXAMFETAMINE SALTS | LABOMED PHARMACEUTICAL COMPANY S.A. (GR) | 2022-12-07 | — | — | EP | disclosed |
| WO-2021136602-A1 | ORAL SOLUTIONS COMPRISING LISDEXAMFETAMINE SALTS | LABOSERVE PHARMACEUTICAL COMPANY S.A. (GR) | 2021-07-08 | — | — | WO | disclosed |